$UGNE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UNIGENE LABORATORIES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in UNIGENE LABORATORIES INC. Get notifications about new insider transactions in UNIGENE LABORATORIES INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 16 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | A | 0.09 | 500,000 | 45,000 | 500,000 | |
May 16 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 184,122 | 27,618 | 6,647,522 | |
May 16 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 154,472 | 23,171 | 5,577,046 | |
May 16 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 310,239 | 46,536 | 11,200,846 | |
May 16 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 351,166 | 52,675 | 12,678,474 | |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | SABATINO THOMAS J JR | Director | Option Exercise | A | 0.04 | 20,000 | 708 | 57,500 | |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | SABATINO THOMAS J JR | Director | Grant | A | 0.00 | 10,000 | 0 | 225,779 | 215.8 K to 225.8 K (+4.63 %) |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Option Exercise | A | 0.04 | 20,000 | 708 | 82,500 | |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Grant | A | 0.00 | 10,000 | 0 | 184,373 | 174.4 K to 184.4 K (+5.73 %) |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Option Exercise | A | 0.04 | 20,000 | 708 | 107,500 | |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 0.00 | 10,000 | 0 | 263,802 | 253.8 K to 263.8 K (+3.94 %) |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 0.04 | 20,000 | 708 | 57,500 | |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Grant | A | 0.00 | 10,000 | 0 | 164,830 | 154.8 K to 164.8 K (+6.46 %) |
May 03 2013 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Option Exercise | A | 0.04 | 75,000 | 2,655 | 75,000 | |
Apr 29 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 2,421,384 | 363,208 | 6,767,354 | |
Apr 29 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 3,880,485 | 582,073 | 5,677,581 | |
Apr 29 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 4,079,950 | 611,993 | 11,402,759 | |
Apr 29 2013 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Option Exercise | D | 0.15 | 4,618,181 | 692,727 | 12,907,024 | |
Jan 04 2013 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 0.13 | 123,077 | 16,000 | 253,802 | 130.7 K to 253.8 K (+94.15 %) |
Jan 04 2013 | UGNE | UNIGENE LABORATORI ... | SABATINO THOMAS J JR | Director | Grant | A | 0.13 | 69,231 | 9,000 | 215,779 | 146.5 K to 215.8 K (+47.24 %) |
Jan 04 2013 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Grant | A | 0.13 | 92,308 | 12,000 | 174,373 | 82.1 K to 174.4 K (+112.48 %) |
Jan 04 2013 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Grant | A | 0.13 | 107,692 | 14,000 | 154,830 | 47.1 K to 154.8 K (+228.46 %) |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. | Option Exercise | A | 0.10 | 556,645 | 55,665 | 1,270,109 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. | Option Exercise | A | 0.25 | 177,025 | 44,256 | 713,464 | |
Dec 11 2012 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | Chief Executive Off ... | Option Exercise | D | 0.25 | 660,000 | 165,000 | 3,000,000 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Option Exercise | A | 0.25 | 17,500 | 4,375 | 87,500 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | SABATINO THOMAS J JR | Director | Option Exercise | A | 0.25 | 7,500 | 1,875 | 37,500 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Zietsman Brian | Chief Financial Off ... | Option Exercise | A | 0.10 | 250,000 | 25,000 | 1,034,600 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Zietsman Brian | Chief Financial Off ... | Option Exercise | A | 0.10 | 625,000 | 62,500 | 784,600 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Zietsman Brian | Chief Financial Off ... | Option Exercise | A | 0.25 | 39,600 | 9,900 | 159,600 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, GRA & QA | Option Exercise | A | 0.10 | 545,000 | 54,500 | 1,031,788 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, GRA & QA | Option Exercise | A | 0.25 | 120,782 | 30,196 | 486,788 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | Chief Scientific Of ... | Option Exercise | A | 0.10 | 630,875 | 63,088 | 1,399,056 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | Chief Scientific Of ... | Option Exercise | A | 0.25 | 190,601 | 47,650 | 768,181 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | President and Gener ... | Option Exercise | A | 0.10 | 722,125 | 72,213 | 2,481,168 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | President and Gener ... | Option Exercise | A | 0.25 | 287,582 | 71,896 | 1,759,043 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | Chief Executive Off ... | Option Exercise | A | 0.10 | 1,000,000 | 100,000 | 3,660,000 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | Chief Executive Off ... | Option Exercise | A | 0.25 | 660,000 | 165,000 | 2,660,000 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Option Exercise | A | 0.25 | 12,500 | 3,125 | 62,500 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 0.25 | 7,500 | 1,875 | 37,500 | |
Sep 07 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | President and Gener ... | Option Exercise | A | 0.10 | 200,000 | 19,800 | 1,471,461 | |
Sep 07 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | President and Gener ... | Option Exercise | A | 0.10 | 200,000 | 19,800 | 1,271,461 | |
Sep 07 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | President and Gener ... | Option Exercise | A | 0.10 | 200,000 | 19,800 | 1,071,461 | |
Jul 18 2012 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Buy | J | 0.00 | 4,302,967 | 0 | 4,302,967 | 0 to 4.3 M |
Jul 18 2012 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Buy | J | 0.00 | 4,844,497 | 0 | 4,844,497 | 0 to 4.8 M |
Jul 18 2012 | UGNE | UNIGENE LABORATORI ... | Victory Park Capital Advisors, ... | Director | Sell | J | 0.00 | 9,147,464 | 0 | 0 | 9.1 M to 0 (-100.00 %) |
Jul 10 2012 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 0.30 | 53,872 | 16,000 | 130,725 | 76.9 K to 130.7 K (+70.10 %) |
Jul 10 2012 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Grant | A | 0.30 | 47,138 | 14,000 | 47,138 | 0 to 47.1 K |
Jul 10 2012 | UGNE | UNIGENE LABORATORI ... | SABATINO THOMAS J JR | Director | Grant | A | 0.30 | 30,303 | 9,000 | 146,548 | 116.2 K to 146.5 K (+26.07 %) |
Jul 10 2012 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Grant | A | 0.30 | 40,404 | 12,000 | 82,065 | 41.7 K to 82.1 K (+96.98 %) |
Jul 06 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | Chief Business Offi ... | Option Exercise | A | 0.30 | 35,775 | 10,625 | 871,461 | |
Jul 06 2012 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 0.30 | 10,125 | 3,007 | 513,450 | |
Jun 04 2012 | UGNE | UNIGENE LABORATORI ... | Steinhauer William Jacob | Option Exercise | A | 0.26 | 50,000 | 13,000 | 519,000 | ||
May 03 2012 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Option Exercise | A | 0.43 | 20,000 | 8,600 | 50,000 | |
May 03 2012 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Grant | A | 0.00 | 10,000 | 0 | 41,661 | 31.7 K to 41.7 K (+31.58 %) |
May 03 2012 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Option Exercise | A | 0.43 | 20,000 | 8,600 | 70,000 | |
May 03 2012 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 0.00 | 10,000 | 0 | 76,853 | 66.9 K to 76.9 K (+14.96 %) |
May 03 2012 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Option Exercise | A | 0.43 | 75,000 | 32,250 | 75,000 | |
Apr 11 2012 | UGNE | UNIGENE LABORATORI ... | Zietsman Brian | Executive Director, ... | Option Exercise | A | 0.44 | 40,000 | 17,600 | 120,000 | |
Apr 11 2012 | UGNE | UNIGENE LABORATORI ... | Zietsman Brian | Executive Director, ... | Option Exercise | A | 0.44 | 40,000 | 17,600 | 80,000 | |
Apr 11 2012 | UGNE | UNIGENE LABORATORI ... | Zietsman Brian | Executive Director, ... | Option Exercise | A | 0.44 | 40,000 | 17,600 | 40,000 | |
Apr 04 2012 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 0.40 | 10,000 | 4,020 | 30,000 | |
Apr 04 2012 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 0.40 | 10,000 | 4,020 | 20,000 | |
Apr 04 2012 | UGNE | UNIGENE LABORATORI ... | WYSZOMIERSKI JACK L | Director | Option Exercise | A | 0.40 | 10,000 | 4,020 | 10,000 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, GRA & QA | Option Exercise | A | 0.46 | 50,000 | 22,750 | 366,006 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, GRA & QA | Option Exercise | A | 0.46 | 50,000 | 22,750 | 316,006 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, GRA & QA | Option Exercise | A | 0.46 | 50,000 | 22,750 | 266,006 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. | Option Exercise | A | 0.46 | 16,666 | 7,583 | 536,439 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. | Option Exercise | A | 0.46 | 16,667 | 7,583 | 519,773 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. | Option Exercise | A | 0.46 | 16,667 | 7,583 | 503,106 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | VP, R&D | Option Exercise | A | 0.46 | 16,666 | 7,583 | 577,580 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | VP, R&D | Option Exercise | A | 0.46 | 16,667 | 7,583 | 560,914 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | VP, R&D | Option Exercise | A | 0.46 | 16,667 | 7,583 | 544,247 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 0.46 | 40,000 | 18,200 | 503,325 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 0.46 | 40,000 | 18,200 | 463,325 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 0.46 | 40,000 | 18,200 | 423,325 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | Chief Business Offi ... | Option Exercise | A | 0.46 | 50,000 | 22,750 | 835,686 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | Chief Business Offi ... | Option Exercise | A | 0.46 | 50,000 | 22,750 | 785,686 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | Chief Business Offi ... | Option Exercise | A | 0.46 | 50,000 | 22,750 | 735,686 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Moskowitz David | CFO | Option Exercise | A | 0.46 | 250,000 | 113,750 | 750,000 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Moskowitz David | CFO | Option Exercise | A | 0.46 | 250,000 | 113,750 | 500,000 | |
Mar 19 2012 | UGNE | UNIGENE LABORATORI ... | Moskowitz David | CFO | Option Exercise | A | 0.46 | 250,000 | 113,750 | 250,000 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 0.65 | 10,125 | 6,581 | 383,325 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 0.65 | 43,200 | 28,080 | 373,200 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, GRA & QA | Option Exercise | A | 0.65 | 27,000 | 17,550 | 216,006 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, GRA & QA | Option Exercise | A | 0.65 | 39,006 | 25,354 | 189,006 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. | Option Exercise | A | 0.65 | 9,720 | 6,318 | 486,439 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. | Option Exercise | A | 0.65 | 41,719 | 27,117 | 476,719 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | Chief Business Offi ... | Option Exercise | A | 0.65 | 35,775 | 23,254 | 685,686 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | Chief Business Offi ... | Option Exercise | A | 0.65 | 49,911 | 32,442 | 649,911 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | VP, R&D | Option Exercise | A | 0.65 | 11,025 | 7,166 | 527,580 | |
Jan 17 2012 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | VP, R&D | Option Exercise | A | 0.65 | 46,555 | 30,261 | 516,555 | |
Jan 09 2012 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 0.55 | 21,661 | 12,000 | 66,853 | 45.2 K to 66.9 K (+47.93 %) |
Jan 09 2012 | UGNE | UNIGENE LABORATORI ... | SABATINO THOMAS J JR | Director | Grant | A | 0.55 | 16,245 | 9,000 | 116,245 | 100 K to 116.2 K (+16.25 %) |
Jan 09 2012 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Grant | A | 0.55 | 25,271 | 14,000 | 212,695 | 187.4 K to 212.7 K (+13.48 %) |
Jan 09 2012 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Grant | A | 0.55 | 21,661 | 12,000 | 31,661 | 10 K to 31.7 K (+216.61 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Odlaug Theron Edwin | Director | Buy | P | 0.53 | 10,000 | 5,300 | 10,000 | 0 to 10 K |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. Ope ... | Buy | P | 0.53 | 2,000 | 1,050 | 13,100 | 11.1 K to 13.1 K (+18.02 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.53 | 7,500 | 3,975 | 60,000 | 52.5 K to 60 K (+14.29 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.53 | 2,500 | 1,313 | 52,500 | 50 K to 52.5 K (+5.00 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | VP, Global Regulato ... | Buy | P | 0.64 | 1,500 | 953 | 1,500 | 0 to 1.5 K |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Buy | P | 0.53 | 2,000 | 1,050 | 2,000 | 0 to 2 K |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Buy | P | 0.57 | 15,000 | 8,475 | 45,192 | 30.2 K to 45.2 K (+49.68 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | SABATINO THOMAS J JR | Director | Buy | P | 0.63 | 100,000 | 62,880 | 100,000 | 0 to 100 K |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Buy | P | 0.53 | 10,000 | 5,275 | 187,424 | 177.4 K to 187.4 K (+5.64 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | VP, Biological R&D | Buy | P | 0.54 | 1,400 | 749 | 202,895 | 201.5 K to 202.9 K (+0.69 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Mayes, Gregory T. | VP, Corp Developmen ... | Buy | P | 0.53 | 2,000 | 1,050 | 2,000 | 0 to 2 K |
Jul 08 2011 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 1.04 | 8,654 | 9,000 | 30,192 | 21.5 K to 30.2 K (+40.18 %) |
Jul 08 2011 | UGNE | UNIGENE LABORATORI ... | MILLER MARVIN | Director | Grant | A | 1.04 | 11,538 | 12,000 | 125,010 | 113.5 K to 125 K (+10.17 %) |
Jul 08 2011 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Grant | A | 1.04 | 11,538 | 12,000 | 177,424 | 165.9 K to 177.4 K (+6.96 %) |
Jul 08 2011 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Grant | A | 1.04 | 17,308 | 18,000 | 332,015 | 314.7 K to 332 K (+5.50 %) |
Jun 21 2011 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Option Exercise | M | 0.66 | 10,000 | 6,600 | 130,000 | |
Jun 21 2011 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Buy | M | 0.66 | 10,000 | 6,600 | 314,707 | 304.7 K to 314.7 K (+3.28 %) |
Jun 17 2011 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Option Exercise | A | 1.24 | 75,000 | 93,000 | 75,000 | |
Jun 15 2011 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | Vice Pres. Biologic ... | Option Exercise | M | 0.31 | 75,000 | 22,875 | 470,000 | |
Jun 15 2011 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | Vice Pres. Biologic ... | Buy | M | 0.31 | 75,000 | 22,875 | 201,495 | 126.5 K to 201.5 K (+59.29 %) |
Jun 06 2011 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 1.04 | 26,667 | 27,734 | 330,000 | |
Jun 06 2011 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 1.04 | 26,667 | 27,734 | 303,333 | |
Jun 06 2011 | UGNE | UNIGENE LABORATORI ... | Thomas Jenene D. | VP of Investor Rela ... | Option Exercise | A | 1.04 | 26,666 | 27,733 | 276,666 | |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | MILLER MARVIN | Director | Option Exercise | A | 1.24 | 20,000 | 24,800 | 121,000 | |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | MILLER MARVIN | Director | Grant | A | 0.00 | 10,000 | 0 | 113,472 | 103.5 K to 113.5 K (+9.66 %) |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Option Exercise | A | 1.24 | 20,000 | 24,800 | 50,000 | |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 0.00 | 10,000 | 0 | 21,538 | 11.5 K to 21.5 K (+86.67 %) |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Option Exercise | A | 1.24 | 20,000 | 24,800 | 70,000 | |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Grant | A | 0.00 | 10,000 | 0 | 165,886 | 155.9 K to 165.9 K (+6.41 %) |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Option Exercise | A | 1.24 | 20,000 | 24,800 | 140,000 | |
May 03 2011 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Grant | A | 0.00 | 10,000 | 0 | 304,707 | 294.7 K to 304.7 K (+3.39 %) |
Jan 07 2011 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Grant | A | 0.78 | 15,385 | 12,000 | 155,886 | 140.5 K to 155.9 K (+10.95 %) |
Jan 07 2011 | UGNE | UNIGENE LABORATORI ... | Tune Joel A. | Director | Grant | A | 0.78 | 11,538 | 9,000 | 11,538 | 0 to 11.5 K |
Jan 07 2011 | UGNE | UNIGENE LABORATORI ... | MILLER MARVIN | Director | Grant | A | 0.78 | 15,385 | 12,000 | 103,472 | 88.1 K to 103.5 K (+17.47 %) |
Jan 07 2011 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Grant | A | 0.78 | 23,077 | 18,000 | 294,707 | 271.6 K to 294.7 K (+8.50 %) |
Jan 05 2011 | UGNE | UNIGENE LABORATORI ... | Mehta Nozer | Vice Pres. Biologic ... | Option Exercise | A | 0.67 | 100,000 | 67,000 | 545,000 | |
Jan 05 2011 | UGNE | UNIGENE LABORATORI ... | Steinhauer William Jacob | Vice President of F ... | Option Exercise | A | 0.67 | 100,000 | 67,000 | 469,000 | |
Jan 05 2011 | UGNE | UNIGENE LABORATORI ... | Tavakkol Roxanne | Vice President | Option Exercise | A | 0.67 | 100,000 | 67,000 | 150,000 | |
Jan 05 2011 | UGNE | UNIGENE LABORATORI ... | Shields Paul | Vice Pres. Mfg. Ope ... | Option Exercise | A | 0.67 | 100,000 | 67,000 | 435,000 | |
Dec 22 2010 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Buy | P | 0.72 | 5,000 | 3,600 | 140,501 | 135.5 K to 140.5 K (+3.69 %) |
Dec 22 2010 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Buy | P | 0.73 | 10,000 | 7,300 | 135,501 | 125.5 K to 135.5 K (+7.97 %) |
Dec 20 2010 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Option Exercise | M | 0.47 | 150,000 | 70,500 | 0 | |
Dec 20 2010 | UGNE | UNIGENE LABORATORI ... | BLOOM ALLEN | Director | Buy | M | 0.47 | 150,000 | 70,500 | 271,630 | 121.6 K to 271.6 K (+123.32 %) |
Dec 22 2010 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Buy | P | 0.74 | 50,000 | 37,000 | 9,147,464 | 9.1 M to 9.1 M (+0.55 %) |
Dec 22 2010 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Buy | P | 0.75 | 50,000 | 37,500 | 9,097,464 | 9 M to 9.1 M (+0.55 %) |
Dec 22 2010 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Buy | P | 0.75 | 50,000 | 37,500 | 9,047,464 | 9 M to 9 M (+0.56 %) |
Dec 17 2010 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Buy | P | 0.72 | 26,100 | 18,792 | 8,997,464 | 9 M to 9 M (+0.29 %) |
Dec 17 2010 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Buy | P | 0.69 | 75,000 | 51,750 | 8,971,364 | 8.9 M to 9 M (+0.84 %) |
Sep 21 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.70 | 8,800 | 6,160 | 50,000 | 41.2 K to 50 K (+21.36 %) |
Sep 21 2010 | UGNE | UNIGENE LABORATORI ... | Steinhauer William Jacob | Vice President of F ... | Buy | P | 0.69 | 5,000 | 3,450 | 85,695 | 80.7 K to 85.7 K (+6.20 %) |
Sep 08 2010 | UGNE | UNIGENE LABORATORI ... | SLUSSER PETER | Director | Buy | P | 0.75 | 2,000 | 1,500 | 59,315 | 57.3 K to 59.3 K (+3.49 %) |
Sep 08 2010 | UGNE | UNIGENE LABORATORI ... | Levy Richard N | Director | Buy | P | 0.72 | 5,000 | 3,600 | 8,896,364 | 8.9 M to 8.9 M (+0.06 %) |
Aug 18 2010 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Buy | P | 0.60 | 17,000 | 10,200 | 125,501 | 108.5 K to 125.5 K (+15.67 %) |
Aug 18 2010 | UGNE | UNIGENE LABORATORI ... | ZVI EIREF | Director | Buy | P | 0.63 | 4,000 | 2,520 | 108,501 | 104.5 K to 108.5 K (+3.83 %) |